Literature DB >> 28264987

Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions.

Yuan Shen1,2, Shanshan Liu1,3, Jiao Fan1,4, Yinghua Jin5, Baolei Tian1, Xiaofei Zheng6, Hanjiang Fu6.   

Abstract

The protein p53 plays a crucial role in the regulation of cellular responses to diverse stresses. Thus, a major priority in cell biology is to define the mechanisms that regulate p53 activity in response to stresses or maintain it at basal levels under normal conditions. Moreover, further investigation is required to establish whether RNA participates in regulating p53's interaction with other proteins. Here, by conducting systematic experiments, we discovered a p53 interactor-hnRNPC-that directly binds to p53, destabilizes it, and prevents its activation under normal conditions. Upon doxorubicin treatment, the lncRNA SNHG1 is retained in the nucleus through its binding with nucleolin and it competes with p53 for hnRNPC binding, which upregulates p53 levels and promotes p53-dependent apoptosis by impairing hnRNPC regulation of p53 activity. Our results indicate that a balance between lncRNA SNHG1 and hnRNPC regulates p53 activity and p53-dependent apoptosis upon doxorubicin treatment, and further indicate that a change in lncRNA subcellular localization under specific circumstances is biologically significant.
© 2017 The Authors.

Entities:  

Keywords:  SNHG1; doxorubicin; hnRNPC; lncRNA; p53

Mesh:

Substances:

Year:  2017        PMID: 28264987      PMCID: PMC5376760          DOI: 10.15252/embr.201643139

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  63 in total

1.  A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagus.

Authors:  Matthew H Kulke; Bingyan Wu; Jeffrey W Clark; Peter C Enzinger; Thomas J Lynch; Michele Vincitore; Ann Michelini; Charles S Fuchs
Journal:  Cancer Invest       Date:  2006 Apr-May       Impact factor: 2.176

Review 2.  p53 RNA interactions: new clues in an old mystery.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

3.  Topoisomerase II-mediated DNA cleavage and religation in the absence of base pairing. Abasic lesions as a tool to dissect enzyme mechanism.

Authors:  P S Kingma; N Osheroff
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

4.  Primary structure differences between proteins C1 and C2 of HeLa 40S nuclear ribonucleoprotein particles.

Authors:  B M Merrill; S F Barnett; W M LeStourgeon; K R Williams
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

5.  The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation.

Authors:  Vidisha Tripathi; Jonathan D Ellis; Zhen Shen; David Y Song; Qun Pan; Andrew T Watt; Susan M Freier; C Frank Bennett; Alok Sharma; Paula A Bubulya; Benjamin J Blencowe; Supriya G Prasanth; Kannanganattu V Prasanth
Journal:  Mol Cell       Date:  2010-09-24       Impact factor: 17.970

6.  Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.

Authors:  Kasandra J-L Riley; Laura A Cassiday; Akash Kumar; L James Maher
Journal:  RNA       Date:  2006-04       Impact factor: 4.942

7.  Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitamin D resistance: a novel response element-binding protein.

Authors:  Hong Chen; Martin Hewison; John S Adams
Journal:  J Biol Chem       Date:  2006-10-27       Impact factor: 5.157

8.  Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment.

Authors:  Kyle J Christian; Matti A Lang; Françoise Raffalli-Mathieu
Journal:  Mol Pharmacol       Date:  2008-02-22       Impact factor: 4.436

9.  Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.

Authors:  C Barone; A Cassano; C Pozzo; D D'Ugo; G Schinzari; R Persiani; M Basso; I M Brunetti; R Longo; A Picciocchi
Journal:  Oncology       Date:  2004       Impact factor: 2.935

10.  The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation.

Authors:  Pin Wang; Yiquan Xue; Yanmei Han; Li Lin; Cong Wu; Sheng Xu; Zhengping Jiang; Junfang Xu; Qiuyan Liu; Xuetao Cao
Journal:  Science       Date:  2014-04-18       Impact factor: 47.728

View more
  35 in total

1.  Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions.

Authors:  Yuan Shen; Shanshan Liu; Jiao Fan; Yinghua Jin; Baolei Tian; Xiaofei Zheng; Hanjiang Fu
Journal:  EMBO Rep       Date:  2017-03-06       Impact factor: 8.807

2.  Down-regulation LncRNA-SNHG15 contributes to proliferation and invasion of bladder cancer cells.

Authors:  Aldhabi Mokhtar; Chuize Kong; Zhe Zhang; Yan Du
Journal:  BMC Urol       Date:  2021-05-20       Impact factor: 2.264

3.  DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.

Authors:  Qiong Wu; Jiali Ma; Wenying Meng; Pingping Hui
Journal:  Cancer Biol Ther       Date:  2019-10-08       Impact factor: 4.742

4.  Overexpression of ST7-AS1 Enhances Apoptosis and Inhibits Proliferation of Papillary Thyroid Carcinoma Cells Via microRNA-181b-5p-Dependent Inhibition Tripartite Motif Containing 3.

Authors:  Yuan Zhao; Xiaoyun Feng; Yonggang Zhao; Huijuan Yang; Chunjie Zhang
Journal:  Mol Biotechnol       Date:  2022-08-27       Impact factor: 2.860

5.  Knockdown of lncRNA BLACAT1 enhances radiosensitivity of head and neck squamous cell carcinoma cells by regulating PSEN1.

Authors:  Caixia Gou; Pengbing Han; Jin Li; Liying Gao; Xuejuan Ji; Fang Dong; Qun Su; Yanping Zhang; Xiaofeng Liu
Journal:  Br J Radiol       Date:  2020-02-12       Impact factor: 3.039

6.  The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p.

Authors:  Mu Xu; Xiaoxiang Chen; Kang Lin; Kaixuan Zeng; Xiangxiang Liu; Bei Pan; Xueni Xu; Tao Xu; Xiuxiu Hu; Li Sun; Bangshun He; Yuqin Pan; Huiling Sun; Shukui Wang
Journal:  Mol Cancer       Date:  2018-09-28       Impact factor: 27.401

7.  Long non-coding RNA SNHG1 suppresses cell migration and invasion and upregulates SOCS2 in human gastric carcinoma.

Authors:  Shanshan Wang; Haibo Han; Junling Meng; Wei Yang; Yunwei Lv; Xianzi Wen
Journal:  Biochem Biophys Rep       Date:  2021-06-17

8.  Long Noncoding RNA PVT1 Promotes Stemness and Temozolomide Resistance through miR-365/ELF4/SOX2 Axis in Glioma.

Authors:  Rui Gong; Zhi-Qiang Li; Kai Fu; Chao Ma; Wei Wang; Jin-Cao Chen
Journal:  Exp Neurobiol       Date:  2021-06-30       Impact factor: 3.261

9.  A Non-Coding RNA Landscape of Bronchial Epitheliums of Lung Cancer Patients.

Authors:  Yanli Lin; Van Holden; Pushpawallie Dhilipkannah; Janaki Deepak; Nevins W Todd; Feng Jiang
Journal:  Biomedicines       Date:  2020-04-13

10.  Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair.

Authors:  Chin-Chuan Chen; Chi-Yuan Chen; Shu-Huei Wang; Chau-Ting Yeh; Shih-Chi Su; Shir-Hwa Ueng; Wen-Yu Chuang; Chuen Hsueh; Tong-Hong Wang
Journal:  Cancers (Basel)       Date:  2018-09-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.